185 related articles for article (PubMed ID: 12355430)
21. Inhibitory effects of IFN-gamma on HIV-1 replication in latently infected cells.
Sarol LC; Imai K; Asamitsu K; Tetsuka T; Barzaga NG; Okamoto T
Biochem Biophys Res Commun; 2002 Mar; 291(4):890-6. PubMed ID: 11866448
[TBL] [Abstract][Full Text] [Related]
22. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.
Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C
J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986
[TBL] [Abstract][Full Text] [Related]
23. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
Croce M; De Ambrosis A; Corrias MV; Pistoia V; Occhino M; Meazza R; Giron-Michel J; Azzarone B; Accolla RS; Ferrini S
Oncogene; 2003 Oct; 22(49):7848-57. PubMed ID: 14586411
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
[TBL] [Abstract][Full Text] [Related]
25. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
26. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
Bohne J; Kräusslich HG
FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 infection and regulation of Tat function in macrophages.
Liou LY; Herrmann CH; Rice AP
Int J Biochem Cell Biol; 2004 Sep; 36(9):1767-75. PubMed ID: 15183343
[TBL] [Abstract][Full Text] [Related]
28. Retinoblastoma gene inhibits transactivation of HIV-LTR linked gene expression upon co-transfection in He La cells.
Prasad MV; Shanmugam G
Biochem Mol Biol Int; 1993 Jan; 29(1):57-62. PubMed ID: 8490568
[TBL] [Abstract][Full Text] [Related]
29. [Study of transactivation effect on transcription by Tat-TAR-system of human immunodeficiency virus type 1 (HIV-1) in non-lymphoid cells HEK293 and Calu-1].
Mingaleeva RN; Chernov IP; Kopantsev EP; Stukacheva EA; Skaptsova NV; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2009; (2):11-5. PubMed ID: 19517804
[TBL] [Abstract][Full Text] [Related]
30. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
31. The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity.
Argyris EG; Kulkosky J; Meyer ME; Xu Y; Mukhtar M; Pomerantz RJ; Williams KJ
Virology; 2004 Dec; 330(2):481-6. PubMed ID: 15567441
[TBL] [Abstract][Full Text] [Related]
32. The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication.
Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A
J Hum Virol; 2001; 4(1):8-15. PubMed ID: 11213934
[TBL] [Abstract][Full Text] [Related]
33. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.
Dis Markers; 1990; 8(1):34-5. PubMed ID: 2178856
[No Abstract] [Full Text] [Related]
34. Targeting of HIV-1 Tat traffic and function by transduction-competent single chain antibodies.
Theisen DM; Pongratz C; Wiegmann K; Rivero F; Krut O; Krönke M
Vaccine; 2006 Apr; 24(16):3127-36. PubMed ID: 16497417
[TBL] [Abstract][Full Text] [Related]
35. Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain.
Ariumi Y; Kaida A; Hatanaka M; Shimotohno K
Biochem Biophys Res Commun; 2001 Sep; 287(2):556-61. PubMed ID: 11554765
[TBL] [Abstract][Full Text] [Related]
36. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.
Christensen HS; Daher A; Soye KJ; Frankel LB; Alexander MR; Lainé S; Bannwarth S; Ong CL; Chung SW; Campbell SM; Purcell DF; Gatignol A
J Virol; 2007 May; 81(10):5121-31. PubMed ID: 17360756
[TBL] [Abstract][Full Text] [Related]
37. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
Liang C; Wainberg MA
AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
[TBL] [Abstract][Full Text] [Related]
38. TAT-mediated transcellular activation of HIV-1 long terminal repeat directed gene expression by HIV-1-infected peripheral blood mononuclear cells.
Thomas CA; Dobkin J; Weinberger OK
J Immunol; 1994 Oct; 153(8):3831-9. PubMed ID: 7930599
[TBL] [Abstract][Full Text] [Related]
39. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
Zhao C; Chen Y; Park J; Kim JB; Tang H
Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 gene expression and replication in neuronal and glial cell lines with immature phenotype: effects of nerve growth factor.
Ensoli F; Ensoli B; Thiele CJ
Virology; 1994 May; 200(2):668-76. PubMed ID: 8178451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]